|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.081 SEK | +12.50% |
|
+8.00% | -18.18% |
| Apr. 30 | BioInvent Announces Evaluating Attana Technology | CI |
| Apr. 25 | Attana AB Enters Third Year of A Five-Year Service and Support Contract with A Leading Health Institute in the US | CI |
Attana AB reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was SEK 8.59 million compared to SEK 7.49 million a year ago. Revenue was SEK 9.15 million compared to SEK 7.96 million a year ago.
Net loss was SEK 16.69 million compared to SEK 10.62 million a year ago. Basic loss per share from continuing operations was SEK 0.081 compared to SEK 0.0623 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -18.18% | 2.86M | |
| -29.76% | 909M | |
| -19.12% | 129M | |
| -7.98% | 67.34M | |
| +6.78% | 60.67M | |
| +1.80% | 53.19M |
ATTANA AB 
